The Association between IgG and Disease Severity Parameters in CF Patients

Assessing disease severity in patients with cystic fibrosis (CF) is essential when directing therapies. Serum immunoglobulin G (IgG) levels increase with disease severity. Lung clearance index (LCI) is recognized as an outcome measure for CF clinical trials. Our aim was to evaluate the correlations...

Full description

Bibliographic Details
Main Authors: Michal Gur, Yael Ben-David, Moneera Hanna, Anat Ilivitzki, Adi Weichhendler, Ronen Bar-Yoseph, Yazeed Toukan, Kamal Masarweh, Lea Bentur
Format: Article
Language:English
Published: MDPI AG 2021-07-01
Series:Journal of Clinical Medicine
Subjects:
Online Access:https://www.mdpi.com/2077-0383/10/15/3316
_version_ 1797525465145016320
author Michal Gur
Yael Ben-David
Moneera Hanna
Anat Ilivitzki
Adi Weichhendler
Ronen Bar-Yoseph
Yazeed Toukan
Kamal Masarweh
Lea Bentur
author_facet Michal Gur
Yael Ben-David
Moneera Hanna
Anat Ilivitzki
Adi Weichhendler
Ronen Bar-Yoseph
Yazeed Toukan
Kamal Masarweh
Lea Bentur
author_sort Michal Gur
collection DOAJ
description Assessing disease severity in patients with cystic fibrosis (CF) is essential when directing therapies. Serum immunoglobulin G (IgG) levels increase with disease severity. Lung clearance index (LCI) is recognized as an outcome measure for CF clinical trials. Our aim was to evaluate the correlations between IgG and disease severity markers. This was a single-center retrospective study, evaluating association between IgG and markers of severity in CF patients (including clinical characteristics, lung spirometry, LCI, clinical scores and computed tomography (CT) scores) during stable conditions. There were 69 patients, age 20.5 ± 11.6 years. Nineteen (27.5%) patients had elevated IgG. IgG correlated positively with LCI (r = 0.342, <i>p</i> = 0.005). IgG was higher in pancreatic insufficient (PI) and patients with liver disease (1504.3 ± 625.5 vs. 1229 ± 276.1 mg/dL in PI vs. PS, <i>p</i> = 0.023, and 1702.6 ± 720.3 vs. 1256.2 ± 345.5 mg/dL with vs. without liver disease, <i>p</i> = 0.001, respectively). IgG also correlated positively with CRP, CT score, and days with antibiotics in the previous year (r = 0.38, <i>p</i> = 0.003; r = 0.435, <i>p</i> = 0.001; and r = 0.361, <i>p</i> = 0.002, respectively), and negatively with FEV1% and SK score (r = −0.527, <i>p</i> < 0.001 and r = −0.613, <i>p</i> < 0.001, respectively). IgG correlated with clinical parameters, pulmonary functions, and imaging. However, this is still an auxiliary test, complementing other tests, including lung function and imaging tests. Larger multi-center longitudinal studies are warranted.
first_indexed 2024-03-10T09:13:14Z
format Article
id doaj.art-adb4138778cd458ba47388bf517bc875
institution Directory Open Access Journal
issn 2077-0383
language English
last_indexed 2024-03-10T09:13:14Z
publishDate 2021-07-01
publisher MDPI AG
record_format Article
series Journal of Clinical Medicine
spelling doaj.art-adb4138778cd458ba47388bf517bc8752023-11-22T05:48:59ZengMDPI AGJournal of Clinical Medicine2077-03832021-07-011015331610.3390/jcm10153316The Association between IgG and Disease Severity Parameters in CF PatientsMichal Gur0Yael Ben-David1Moneera Hanna2Anat Ilivitzki3Adi Weichhendler4Ronen Bar-Yoseph5Yazeed Toukan6Kamal Masarweh7Lea Bentur8Pediatric Pulmonary Institute and CF Center, Rappaport Children’s Hospital, Rambam Health Care Campus, Haifa 3109601, IsraelPediatric Pulmonary Institute and CF Center, Rappaport Children’s Hospital, Rambam Health Care Campus, Haifa 3109601, IsraelPediatric Pulmonary Institute and CF Center, Rappaport Children’s Hospital, Rambam Health Care Campus, Haifa 3109601, IsraelRappaport Faculty of Medicine, Technion—Israel Institute of Technology, Efron St 1, Haifa 3525422, IsraelPediatric Pulmonary Institute and CF Center, Rappaport Children’s Hospital, Rambam Health Care Campus, Haifa 3109601, IsraelPediatric Pulmonary Institute and CF Center, Rappaport Children’s Hospital, Rambam Health Care Campus, Haifa 3109601, IsraelPediatric Pulmonary Institute and CF Center, Rappaport Children’s Hospital, Rambam Health Care Campus, Haifa 3109601, IsraelPediatric Pulmonary Institute and CF Center, Rappaport Children’s Hospital, Rambam Health Care Campus, Haifa 3109601, IsraelPediatric Pulmonary Institute and CF Center, Rappaport Children’s Hospital, Rambam Health Care Campus, Haifa 3109601, IsraelAssessing disease severity in patients with cystic fibrosis (CF) is essential when directing therapies. Serum immunoglobulin G (IgG) levels increase with disease severity. Lung clearance index (LCI) is recognized as an outcome measure for CF clinical trials. Our aim was to evaluate the correlations between IgG and disease severity markers. This was a single-center retrospective study, evaluating association between IgG and markers of severity in CF patients (including clinical characteristics, lung spirometry, LCI, clinical scores and computed tomography (CT) scores) during stable conditions. There were 69 patients, age 20.5 ± 11.6 years. Nineteen (27.5%) patients had elevated IgG. IgG correlated positively with LCI (r = 0.342, <i>p</i> = 0.005). IgG was higher in pancreatic insufficient (PI) and patients with liver disease (1504.3 ± 625.5 vs. 1229 ± 276.1 mg/dL in PI vs. PS, <i>p</i> = 0.023, and 1702.6 ± 720.3 vs. 1256.2 ± 345.5 mg/dL with vs. without liver disease, <i>p</i> = 0.001, respectively). IgG also correlated positively with CRP, CT score, and days with antibiotics in the previous year (r = 0.38, <i>p</i> = 0.003; r = 0.435, <i>p</i> = 0.001; and r = 0.361, <i>p</i> = 0.002, respectively), and negatively with FEV1% and SK score (r = −0.527, <i>p</i> < 0.001 and r = −0.613, <i>p</i> < 0.001, respectively). IgG correlated with clinical parameters, pulmonary functions, and imaging. However, this is still an auxiliary test, complementing other tests, including lung function and imaging tests. Larger multi-center longitudinal studies are warranted.https://www.mdpi.com/2077-0383/10/15/3316cystic fibrosisimmunoglobulin Glung clearance indexdisease severitycomputed tomography
spellingShingle Michal Gur
Yael Ben-David
Moneera Hanna
Anat Ilivitzki
Adi Weichhendler
Ronen Bar-Yoseph
Yazeed Toukan
Kamal Masarweh
Lea Bentur
The Association between IgG and Disease Severity Parameters in CF Patients
Journal of Clinical Medicine
cystic fibrosis
immunoglobulin G
lung clearance index
disease severity
computed tomography
title The Association between IgG and Disease Severity Parameters in CF Patients
title_full The Association between IgG and Disease Severity Parameters in CF Patients
title_fullStr The Association between IgG and Disease Severity Parameters in CF Patients
title_full_unstemmed The Association between IgG and Disease Severity Parameters in CF Patients
title_short The Association between IgG and Disease Severity Parameters in CF Patients
title_sort association between igg and disease severity parameters in cf patients
topic cystic fibrosis
immunoglobulin G
lung clearance index
disease severity
computed tomography
url https://www.mdpi.com/2077-0383/10/15/3316
work_keys_str_mv AT michalgur theassociationbetweenigganddiseaseseverityparametersincfpatients
AT yaelbendavid theassociationbetweenigganddiseaseseverityparametersincfpatients
AT moneerahanna theassociationbetweenigganddiseaseseverityparametersincfpatients
AT anatilivitzki theassociationbetweenigganddiseaseseverityparametersincfpatients
AT adiweichhendler theassociationbetweenigganddiseaseseverityparametersincfpatients
AT ronenbaryoseph theassociationbetweenigganddiseaseseverityparametersincfpatients
AT yazeedtoukan theassociationbetweenigganddiseaseseverityparametersincfpatients
AT kamalmasarweh theassociationbetweenigganddiseaseseverityparametersincfpatients
AT leabentur theassociationbetweenigganddiseaseseverityparametersincfpatients
AT michalgur associationbetweenigganddiseaseseverityparametersincfpatients
AT yaelbendavid associationbetweenigganddiseaseseverityparametersincfpatients
AT moneerahanna associationbetweenigganddiseaseseverityparametersincfpatients
AT anatilivitzki associationbetweenigganddiseaseseverityparametersincfpatients
AT adiweichhendler associationbetweenigganddiseaseseverityparametersincfpatients
AT ronenbaryoseph associationbetweenigganddiseaseseverityparametersincfpatients
AT yazeedtoukan associationbetweenigganddiseaseseverityparametersincfpatients
AT kamalmasarweh associationbetweenigganddiseaseseverityparametersincfpatients
AT leabentur associationbetweenigganddiseaseseverityparametersincfpatients